About AHC

We are Aerodigestive Health Corporation (AHC), a "One Health" MedTech startup company advancing aerodigestive health through game-changing innovations for humans and animals.

​

Our company originated from Lever Scientific LLC, which was established in 2013 to bring Dr. Teresa Lever’s leading-edge research and technologies to market. As our portfolio grew—including the successful launch of FluoroKennel—we recognized the need for a broader organization to manage and accelerate these advancements. In 2023, we incorporated AHC as a Delaware C Corporation, building on Lever Scientific’s legacy to develop impactful solutions in aerodigestive health.

​

AHC employs a collaborative approach to innovation, partnering with leading academic institutions and forward-thinking companies to develop, test, and validate new healthcare solutions. We work closely with industry partners, suppliers, and technology leaders to co-develop and bring novel technologies to market. SLP Fusion, our dedicated service company, serves as a real-world test bed for select technologies, allowing us to refine our offerings and ensure they meet the highest standards of performance and reliability. With multiple product lines and a commitment to strategic partnerships, sublicensing, and direct sales, we focus on scaling our solutions globally. This approach accelerates the commercialization of game-changing products and creates valuable opportunities for investors, suppliers, and partners to participate in advancing aerodigestive health solutions worldwide.

​

We are driven to deliver transformative aerodigestive health solutions that bring hope and healing to the people and animals who most desperately need them—ensuring our innovations make a real difference where it matters most.